NCT05798819 2023-04-05A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical CancerGuangzhou Gloria Biosciences Co., Ltd.Phase 3 Not yet recruiting424 enrolled